Navigation Links
Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
Date:9/3/2009

the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of the Company's Specialty Pharmaceutical and Human Genetic Therapies products, as well as the ability to secure and integrate new products for commercialization and/or development; government regulation of the Company's products; the Company's ability to manufacture its products in sufficient quantities to meet demand; the impact of competitive therapies on the Company's products; the Company's ability to register, maintain and enforce patents and other intellectual property rights relating to its products; the Company's ability to obtain and maintain government and other third-party reimbursement for its products; and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission.

    For further in
'/>"/>
SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014  Nearly 8,000 attendees will converge in ... Retail Business Conference (RBC), taking place July 23-26 at ... event encourages pharmacists to "Lead Change" in the pharmacy ... for their future. "RBC is the ... their peers and learn new ways they can lead ...
(Date:7/23/2014)... CITY, Calif. , July 23, 2014  Cardica, Inc. ... release financial results for its fiscal fourth quarter and year ... the markets close. Cardica,s management will host a conference call ... and provide an update on the company,s business. ... August 7, 2014, at 4:30 p.m. Eastern Time via phone, ...
(Date:7/23/2014)... NEW YORK , July 23, 2014  Dompe, a ... of rare diseases, announces that rhNGF (Recombinant Human Nerve Growth ... American Food and Drug Administration (FDA). The ... designated as an orphan drug for the treatment of neurotrophic ... in 5,000 people 1 and is currently without a ...
Breaking Medicine Technology:Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4
... 28, 2011 Streamline Health Solutions, Inc. (Nasdaq: ... workflow solutions for hospitals, announced today that two of ... system in North Carolina, contracted with Streamline Health to ... Resources, which began the beta phase of integration earlier ...
... Inc. (Nasdaq: PCRX ), an emerging specialty pharmaceutical ... quarter ended June 30, 2011 will be released before the ... team will host a conference call to discuss the company,s ... 11, 2011 at 9 a.m. ET. The call can be ...
Cached Medicine Technology:Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems 2Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems 3Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems 4Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2011 Financial Results Webcast and Conference Call 2
(Date:7/23/2014)... and Bioengineering will host its second Edward C. Nagy ... NIH campus. There will be ten exciting presentations from ... research. , WHO: , ... Voltage Sensor, Quyen Nguyen, Univ. of California, San ... Imaging during Surgery, Jan Grimm, Memorial ...
(Date:7/23/2014)... Thousands of DePuy Pinnacle hip lawsuits ... federal multidistrict litigation underway in U.S. District Court, Northern ... an Order dated July 18th, U.S. District Judge Ed ... a $1,000 fee for the preservation and return of ... things, the Order noted that there is no evidence ...
(Date:7/23/2014)... 2014 The voice on the recording was low ... the news he was infected with the human immunodeficiency virus (HIV) ... and next thing you know I was on the floor flat ... message was hopeful when the recording ended less than 10 minutes ... . . because it is just God setting you up ...
(Date:7/23/2014)... 2014 (HealthDay News) --,Jealousy may not be the sole ... get downright possessive when it comes to the love ... toward what was actually a stuffed dog, the real ... the stuffed dog aside, report researchers from the University ... only surfaced when owners were attending to the stuffed ...
(Date:7/23/2014)... is a disease of the genome resulting from a ... our parents strong or weak predispositions to developing certain ... mutations in our cells throughout our lifetime. Although the ... long time, researchers were not able to measure the ... A team of geneticists from the University of Geneva ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 4Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3Health News:Dogs Can Get Jealous, Too 2Health News:Genetics of cancer: Non-coding DNA can finally be decoded 2
... Uncovering some science behind the type of intuition known as ... that a woman can tell whether a man is straight ... ovulating. Women also appear to have a heightened sensitivity ... romantic notions or mating aspirations, the new study revealed. ...
... Rochelle, NY, June 27, 2011The nature of cell phone ... the quality of their relationship, and much depends on ... of the conversation, according to an illuminating study reported ... a peer-reviewed journal published by Mary Ann Liebert, Inc. ...
... characterised by heroes and masculinity. This image is commonly ... in the firemen calendars produced by the firefighters themselves. ... profession make efforts to maintain and take advantage of ... Mathias Ericson, the author of a doctoral thesis based ...
... Pryor, M.D., president and CEO of Scott & White Healthcare, ... 65 nationally to be named to Becker,s Hospital Review annual ... their array of experience in medicine and management, these men ... health care industry. According to Becker,s, physician ...
... HealthDay Reporter , SATURDAY, June 25 (HealthDay News) ... in life expectancy between people with type 1 diabetes and ... expectancy at birth for someone diagnosed with type 1 diabetes ... compared to 72.4 years for the general population. But, for ...
... most prevalent illicit drug used by teenagers and adults around ... the United States report smoking it, and most high schoolers ... many people, smoking pot is no big deal. They cite ... is doing it." Denise Walker, co-director of the University ...
Cached Medicine News:Health News:Ovulation Seems to Aid Women's 'Gaydar' 2Health News:Firefighters are no macho men 2Health News:Life Expectancy Improves for Type 1 Diabetics 2Health News:Life Expectancy Improves for Type 1 Diabetics 3Health News:2 talks with teens leads to less marijuana use for at least a year 2Health News:2 talks with teens leads to less marijuana use for at least a year 3
... Pump™ is a quiet, compact, efficient vacuum ... The oil-free design and TEFLON®/ETFE coated vapor ... reliability and reduced maintenance. Unique features include ... protection, and a 1-liter post-pump solvent recovery ...
Produces vacuum pressures required for 96 well kits...
... DirectPrep 96 plates and MinElute 96 ... sample handling and accelerated processing; ... plates and MinElute 96 UF PCR ... of internal components by simply separating ...
For vacuum-driven processing of spin columns; Reduced sample handling and accelerated processing; Parallel sample processing using QIAGEN spin columns; Easy cleaning of internal components by simpl...
Medicine Products: